Published in Ann Intern Med on February 01, 1966
Nevoid basal cell carcinoma syndrome. Can Med Assoc J (1971) 1.87
Recessively inherited costovertebral segmentation defect with mesomelia and peculiar facies (Covesdem syndrome): A new genetic entity? J Med Genet (1978) 1.29
Ancell-Spiegler cylindromas (turban tumours) and Brooke-Fordyce Trichoepitheliomas: evidence for a single genetic entity. J Med Genet (1968) 0.85
[Basal cell nevus syndrome with retinopathia pigmentosa, recurrent vitreous body hemorrhage and chromosome aberrations]. Arch Dermatol Forsch (1971) 0.81
Congenital hydrocephalus and the basal cell nevus syndrome. Can Med Assoc J (1985) 0.77
The basal cell naevus syndrome. Report of a family with anosmia and a case of hypogonadotrophic hypopituitarism. J Med Genet (1973) 0.76
Cancer of the ovary. Br Med J (1979) 0.75
Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet (1966) 3.26
Diagnosis and classification of the polycythemias. Semin Hematol (1975) 2.74
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol (1965) 2.16
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol (1986) 2.10
Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med (1970) 1.80
Hereditary defects of dentin. Dent Clin North Am (1975) 1.77
Angiosarcoma of the liver following vinyl chloride exposure. JAMA (1974) 1.77
Visual system anomalies in human ocular albinos. Science (1978) 1.75
Effects of alpha-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol (1996) 1.72
The Saethre-Chotzen syndrome. Birth Defects Orig Artic Ser (1975) 1.72
Asymmetric visually evoked potentials in human albinos: evidence for visual system anomalies. Invest Ophthalmol (1974) 1.66
Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma. Ann Intern Med (1967) 1.62
Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Cancer Chemother Rep (1970) 1.55
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
The ichthyosiform dermatoses. II. Autoradiographic studies of epidermal proliferation. J Invest Dermatol (1966) 1.54
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med (1975) 1.53
Ichthyosiform dermatoses. Classification based on anatomic and biometric observations. Arch Dermatol (1966) 1.52
Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49
Studies of bilirubin kinetics in normal adults. J Clin Invest (1969) 1.47
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Albinism. Surv Ophthalmol (1986) 1.41
Rectal abscesses in cancer patients. Lancet (1972) 1.40
Manifestations of genetic diseases in the human pulp. Oral Surg Oral Med Oral Pathol (1971) 1.40
Immunologic reactivity in patients with leprosy. Ann Intern Med (1969) 1.39
Mucous cell hyperplasia in an odontogenic cyst from a patient with Muir-Torre syndrome. J Oral Maxillofac Surg (1990) 1.39
Malformation syndromes. A selected miscellany. Birth Defects Orig Artic Ser (1975) 1.35
Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis. Br Med J (1966) 1.34
Control of keratinization with alpha-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch Dermatol (1974) 1.33
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
Autosomal recessively inherited ocular albinism. A new form of ocular albinism affecting females as severely as males. Arch Ophthalmol (1978) 1.33
Reticuloendothelial system phagocytic function in patients with Hodgkin's disease. J Clin Invest (1967) 1.30
Controlled studies in clinical cancer research. N Engl J Med (1972) 1.30
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
Hermansky-Pudlak syndrome. Ophthalmic findings. Ophthalmology (1988) 1.26
Taurodontism, an isolated trait associated with syndromes and X-chromosomal aneuploidy. Am J Hum Genet (1980) 1.25
Preparation and properties of specifically labeled radiochemically stable 3H-bilirubin. J Lab Clin Med (1970) 1.24
Medical and dental findings in the Brandywine isolate. Ala J Med Sci (1966) 1.24
Albinism. Adv Hum Genet (1971) 1.23
Autosomal recessive oculocutaneous albinism in man. Evidence for genetic heterogeneity. Am J Hum Genet (1970) 1.23
Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest (1972) 1.22
Accuracy of dermatologic diagnosis by television. Arch Dermatol (1972) 1.21
Ophthalmologic, biochemical, platelet, and ultrastructural defects in the various types of oculocutaneous albinism. J Invest Dermatol (1973) 1.19
IgE in atopic dermatitis. Arch Dermatol (1971) 1.17
Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterology (1971) 1.16
Lactic acidosis in malignancy and observations on its possible pathogenesis. Ann N Y Acad Sci (1974) 1.16
The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: Introduction. Am Rev Respir Dis (1984) 1.14
Abnormal visual pathways in the brain of a human albino. Brain Res (1975) 1.14
Studies of platelets in a variant of the Hermansky-Pudlak syndrome. Am J Pathol (1971) 1.13
Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther (1973) 1.12
Elevated urinary dolichol excretion in the Hermansky-Pudlak syndrome. Indicator of lysosomal dysfunction. Am J Med (1987) 1.12
Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol (1984) 1.12
Nonspecificity of characteristic cells in mycosis fungoides. Arch Dermatol (1971) 1.11
Bilirubin turnover studies in normal and pathologic states using bilirubin-14C. Ann Intern Med (1968) 1.10
Agenesis of succedaneous teeth: an expression of the homozygous state of the gene for the pegged or missing maxillary lateral incisor trait. Am J Med Genet (1987) 1.09
Partial expression of sex-linked recessive amelogenesis imperfecta in females compatible with the Lyon hypothesis. Oral Surg Oral Med Oral Pathol (1967) 1.08
Dental caries in gnotobiotic rats infected with a variety of Lactobacillus acidophilus. Arch Oral Biol (1966) 1.08
Hypoplastic enamel, onycholysis, and hypohidrosis inherited as an autosomal dominant trait. A review of ectodermal dysplasia syndromes. Oral Surg Oral Med Oral Pathol (1975) 1.08
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.07
Inherited defects in tooth structure. Birth Defects Orig Artic Ser (1971) 1.07
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. Cancer Treat Rep (1984) 1.05
Prolonged ultraviolet light-induced erythema and the cutaneous carcinoma phenotype. J Invest Dermatol (1976) 1.05
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Syndrome of amelogenesis imperfecta, nephrocalcinosis, impaired renal concentration, and possible abnormality of calcium metabolism. Am J Med Genet (1985) 1.05
Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med (1994) 1.04
Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res (1982) 1.04
Mycosis fungoides d'emblée: a rare presentation of cutaneous T-cell lymphoma. Cancer (1982) 1.04
Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss. J Clin Invest (1968) 1.04
Studies on the biosynthesis production of bilirubin-C14: an improved method utilizing delta-aminolevulinic acid-4-C14 in dogs. J Lab Clin Med (1966) 1.03
A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism. Proc Natl Acad Sci U S A (1991) 1.01
A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. Am J Hum Genet (1993) 1.01
Hairbulb tyrosinase activity in oculocutaneous albinism. Nature (1976) 1.01
Heterogeneity in gingival fibromatosis. Birth Defects Orig Artic Ser (1971) 1.01
Detection of heterozygotes for tyrosinase-negative oculocutaneous albinism by hairbulb tyrosinase assay. Am J Hum Genet (1977) 1.00
Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets. Am J Pathol (1972) 1.00
Albinism in England. Birth Defects Orig Artic Ser (1982) 1.00
Hermansky-Pudlak syndrome in a Swiss population. Dermatology (1993) 0.99
Amish albinism: a distinctive autosomal recessive phenotype. Am J Hum Genet (1970) 0.98
Auditory brainstem anomalies in human albinos. Science (1980) 0.98
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol (1989) 0.97
Autosomal recessive pigmented hypomaturation amelogenesis imperfecta. Report of a kindred. Oral Surg Oral Med Oral Pathol (1973) 0.97
Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results. Arch Dermatol (1977) 0.97
Alterations of lesions of mycosis fungoides lymphoma by direct imposition of delayed hypersensitivity reactions. Cancer (1968) 0.96
Prevalence o f malocclusion in Chippewa Indian children. J Dent Res (1968) 0.96
A new approach to quantitation of the various sources of bilrubin in man. J Lab Clin Med (1976) 0.96
The association of the urobilin "early peak" and erythropoiesis in man. J Clin Invest (1966) 0.95
Patterns and sequence of tissue changes in incipient and evolving lesions of psoriasis. Arch Dermatol (1972) 0.95
Psychosocial factors in low-incidence genetic disease: the case of osteogenesis imperfecta. Soc Work Health Care (1976) 0.95
Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med (1984) 0.95
Hematologic and biochemical studies in a case of lead poisoning. Am J Med (1970) 0.94
Responses of mycosis fungoides to intensive external treatment with nitrogen mustard. Arch Dermatol (1970) 0.94
Combined chemical and electron microscopic studies of pheomelanosomes in human red hair. J Invest Dermatol (1983) 0.93
Early clinical studies with lapachol (NSC-11905). Cancer Chemother Rep 2 (1974) 0.93
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity. Med Pediatr Oncol (1976) 0.93
Interpretation of plasma bilirubin levels based on studies with radioactive bilirubin. JAMA (1971) 0.93
Autosomal dominant hypodontia with nail dysgenesis. Report of twenty-nine cases in six families. Oral Surg Oral Med Oral Pathol (1975) 0.92
Antimitotic effects of hydroxyurea and its derivatives: structure-activity relationships. J Invest Dermatol (1974) 0.92